Physician profile
Daniel Zukowski
NPI 1336671916
$20,963.68
in general payments reported to CMS, 2019-2025
20 companies · $919 in 2025
The $919 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $111 · 2021: $10K · 2022: $7,640 · 2023: $1,144 · 2024: $901 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,963.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,475.59 | 2021-2024 | Intellis Adaptivestim, Osteocool Rf Ablation System, Accurian |
| Abbott Laboratories | $5,461.04 | 2022-2024 | Proclaim |
| Nevro Corp. | $1,015.47 | 2022-2024 | Senza |
| Relievant Medsystems, INC. | $982.01 | 2022-2023 | Intracept |
| Boston Scientific Corporation | $714.94 | 2021-2025 | Intracept, Intracept Rf Probe, Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $286.81 | 2022-2024 | Nalu Neurostimulation System |
| Globus Medical, INC. | $251.14 | 2025 | Senza |
| Si-Bone, INC. | $220.59 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $197.34 | 2022-2023 | Relistor |
| Spinal Simplicity, LLC | $193.57 | 2022 | |
| Spr Therapeutics, INC | $190.36 | 2022-2023 | Sprint Pns System |
| Stryker Corporation | $149.25 | 2022 | |
| Mml US, INC. | $143.56 | 2022 | |
| Vertos Medical, INC. | $137.61 | 2022 | |
| Avanos Medical | $125.55 | 2024 | Generator |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $124.98 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $110.72 | 2020 | |
| Abbvie INC. | $80.82 | 2022-2023 | Botox, Ubrelvy |
| Biohaven Pharmaceutical Holding Company Ltd. | $65.03 | 2022 | |
| Collegium Pharmaceutical, INC. | $37.30 | 2023 | Belbuca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Zukowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.